格林生物
(301688)
| 流通市值：8.69亿 | | | 总市值：44.61亿 |
| 流通股本：2598.50万 | | | 总股本：1.33亿 |
| 利润表 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 营业总收入 | 875,693,674.17 | 608,180,576.57 | 318,053,000 | 1,074,915,761.58 |
| 营业总成本 | 714,121,494.38 | 489,935,155.05 | - | 865,197,564.17 |
| 其他经营收益 | | | | |
| 营业利润 | 160,372,201.66 | 114,623,131.3 | 59,795,900 | 206,508,915.13 |
| 利润总额 | 160,330,542.12 | 114,580,271.74 | 59,742,300 | 206,283,684.21 |
| 净利润 | 138,813,732.55 | 98,521,225.78 | - | 178,959,071.13 |
| 每股收益 | | | | |
| 其他综合收益 | -37,743.95 | 325,758.17 | - | 206,475.95 |
| 综合收益总额 | 138,775,988.6 | 98,846,983.95 | - | 179,165,547.08 |
| 资产负债表 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 流动资产: | | | | |
| 流动资产合计 | 1,635,690,049.84 | 795,644,763.14 | - | 705,517,752.67 |
| 非流动资产: | | | | |
| 非流动资产合计 | 1,065,092,833.39 | 1,072,243,851.98 | - | 1,072,186,173.75 |
| 资产总计 | 2,700,782,883.23 | 1,867,888,615.12 | 1,850,300,000 | 1,777,703,926.42 |
| 流动负债: | | | | |
| 流动负债合计 | 674,364,262.26 | 626,207,947.65 | - | 539,372,554.06 |
| 非流动负债: | | | | |
| 非流动负债合计 | 363,318,591.01 | 390,595,005.18 | - | 489,648,091.6 |
| 负债合计 | 1,037,682,853.27 | 1,016,802,952.83 | 1,049,576,900 | 1,029,020,645.66 |
| 所有者权益(或股东权益): | | | | |
| 归属于母公司股东权益合计 | 1,663,100,029.96 | 851,085,662.29 | 800,723,100 | 748,683,280.76 |
| 股东权益合计 | 1,663,100,029.96 | 851,085,662.29 | - | 748,683,280.76 |
| 负债和股东权益合计 | 2,700,782,883.23 | 1,867,888,615.12 | - | 1,777,703,926.42 |
| 现金流量表 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 经营活动产生的现金流量: | | | | |
| 经营活动现金流入小计 | 940,059,089.06 | 594,157,448.69 | - | 1,151,374,446.67 |
| 经营活动现金流出小计 | 813,260,064.25 | 502,213,938.02 | - | 992,854,098.78 |
| 经营活动产生的现金流量净额 | 126,799,024.81 | 91,943,510.67 | 18,044,700 | 158,520,347.89 |
| 投资活动产生的现金流量: | | | | |
| 投资活动现金流入小计 | 8,275.07 | 7,336.29 | - | 1,562,360.66 |
| 投资活动现金流出小计 | 85,368,620.55 | 60,612,663 | - | 88,419,595.15 |
| 投资活动产生的现金流量净额 | -85,360,345.48 | -60,605,326.71 | - | -86,857,234.49 |
| 筹资活动产生的现金流量: | | | | |
| 筹资活动现金流入小计 | 1,353,362,019.66 | 371,073,485.11 | - | 469,097,902.58 |
| 筹资活动现金流出小计 | 582,780,568.4 | 372,177,908.87 | - | 527,468,765.64 |
| 筹资活动产生的现金流量净额 | 770,581,451.26 | -1,104,423.76 | - | -58,370,863.06 |
| 汇率变动对现金及现金等价物的影响 | -5,023,455.81 | -3,580,010.67 | - | 4,413,905.42 |
| 现金及现金等价物净增加额 | 806,996,674.78 | 26,653,749.53 | - | 17,706,155.76 |
| 期末现金及现金等价物余额 | 878,834,434.37 | 98,491,509.12 | - | 71,837,759.59 |
| 补充资料: | | | | |
| 现金及现金等价物的净增加额 | - | 26,653,749.53 | - | 17,706,155.76 |